Regression of cervical high-grade squamous intraepithelial lesions (HSIL/CIN2) managed expectantly.


Journal

Journal of gynecology obstetrics and human reproduction
ISSN: 2468-7847
Titre abrégé: J Gynecol Obstet Hum Reprod
Pays: France
ID NLM: 101701588

Informations de publication

Date de publication:
Oct 2022
Historique:
received: 15 05 2022
revised: 09 07 2022
accepted: 13 07 2022
pubmed: 17 7 2022
medline: 21 9 2022
entrez: 16 7 2022
Statut: ppublish

Résumé

Many women with cervical high-grade squamous intraepithelial lesions (HSIL/CIN2) are managed expectantly, because about half of them will regress spontaneously, thus avoiding systematic loop electrosurgical excision procedure and related adverse effects. However, most of the guidelines have restricted this strategy to the youngest women. The objectives of our study were to determine the rate and the predictors of regression of HSIL/CIN2 managed expectantly. This retrospective study included 128 patients under 40 years of age (median 29, range 21-39), and HSIL/CIN2 diagnosed by biopsy between 2012 and 2019. They were followed-up without treatment in the department of gynecology at Bordeaux University Hospital, France. The regression of HSIL/CIN2 was defined by the regression or the disappearance of initial colposcopic findings, cytological and/or histological results. The lesion spontaneously regressed or disappeared in 76 (59%) patients during a median follow-up of 25 months (range, 7-86). In the multivariable analysis, minor change at colposcopy (odds ratio OR = 2.8 (CI95% 1.2-6.9), P = 0.02), low grade lesions (ASC-US/LSIL) by cytology (OR = 4.1 (CI95% 1.7-10.1), P < 0.001), and infection by HPV other than HPV-16 (OR = 5.4 (CI95% 2.3-13.9), P < 0.001) predicted the spontaneous regression of HSIL/CIN2. Colposcopic findings, cytological results, and HPV genotyping, but not the age, were baseline factors predicting the evolution of HSIL/CIN2 in patients under 40.

Identifiants

pubmed: 35842125
pii: S2468-7847(22)00126-X
doi: 10.1016/j.jogoh.2022.102442
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

102442

Informations de copyright

Copyright © 2022 Elsevier Masson SAS. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest None.

Auteurs

Audrey Nourrisson (A)

Department of Gynecology, University Hospital of Bordeaux, Bordeaux, France.

Helene Lepetit (H)

Department of Public Health, University Hospital of Bordeaux, Bordeaux, France.

Marion Marty (M)

Department of Pathology, University Hospital of Bordeaux, Bordeaux, France.

Isabelle Garrigue (I)

Laboratory of Virology, University Hospital of Bordeaux, Bordeaux, France; UMR 5234, Microbiology and Pathogenicity, University of Bordeaux, Bordeaux, France.

Jean-Luc Brun (JL)

Department of Gynecology, University Hospital of Bordeaux, Bordeaux, France; UMR 5234, Microbiology and Pathogenicity, University of Bordeaux, Bordeaux, France. Electronic address: jean-luc.brun@chu-bordeaux.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH